Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
7
×
boston blog main
investing
7
×
life sciences
national blog main
boston top stories
clinical trials
deals
fda
national top stories
startups
san francisco blog main
medical device
new york blog main
new york top stories
perceptive advisors
roche
san francisco top stories
venture capital
480 biomedical
abbott laboratories
adel malek
akouos
allosteric
antisense oligonucleotide
arsenal medical
astellas pharmaceuticals
atlas venture
aton partners
atopic dermatitis
autoimmune disorders
avapritinib
benzodiazepines
biofourmis
biogen
biovotion
blackstone group
blackstone life sciences
blueprint medicines
What
medicines
new
therapeutics
treat
address
developing
drug
fda
ipo
million
raised
absorb
adds
affects
ago
aims
allosteric
americans
analytics
approval
approved
backed
biofourmis
biotech
blueprint
body
brain
builds
called
cancer
candidate
cause
ceo
cerevasc
clinic
company
currently
data
date
debut
Language
unset
7
×
Current search:
unset
×
investing
×
boston
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
3 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds